prikaz prve stranice dokumenta Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases
  Preuzmi
PDF 846.32 KB
Izlaganje na skupu
Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases
Na: 26th Congress of the European Hematology Association. Online, Nizozemska, 2021. https://doi.org/10.1097/HS9.0000000000000566
Kolačević Zeljković, Mateja; Bulj, Nikola; Bašić-Kinda, Sandra; Milunović, Vibor; Čaržavec, Dubravka; Jakšić, Ozren; Vodanović, Marijo; Ostojić-Kolonić, Slobodanka; Gaćina, Petar; Dujmović, D; Željković, Ivan; Pejša, Vlatko; Aurer, Igor

Citirajte ovaj rad

Kolačević Zeljković, M., Bulj, N., Bašić Kinda, S., Milunović, V., Čaržavec, D., Jakšić, O. ... Aurer, I. Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases [PowerPoint prezentacija]. Preuzeto s https://urn.nsk.hr/urn:nbn:hr:220:516465

Kolačević Zeljković, Mateja, et al. "Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases." 26th Congress of the European Hematology Association, 09.06.2021.-17.06.2021., Online, Nizozemska. Prezentacija. https://urn.nsk.hr/urn:nbn:hr:220:516465

Kolačević Zeljković, Mateja, Nikola Bulj, Sandra Bašić Kinda, Vibor Milunović, Dubravka Čaržavec, Ozren Jakšić, Marijo Vodanović, et al. "Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases." Prezentacija sa skupa 26th Congress of the European Hematology Association, Online, Nizozemska, 09.06.2021.-17.06.2021. https://urn.nsk.hr/urn:nbn:hr:220:516465

Kolačević Zeljković, M., et al. 'Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases' [Prezentacija], 26th Congress of the European Hematology Association. 09.06.2021.-17.06.2021. Preuzeto s: https://urn.nsk.hr/urn:nbn:hr:220:516465

Kolačević Zeljković M, Bulj N, Bašić Kinda S, Milunović V, Čaržavec D, Jakšić O, i sur.. Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases. [Prezentacija] [pristupljeno 08.12.2024.] Dostupno na: https://urn.nsk.hr/urn:nbn:hr:220:516465

M. Kolačević Zeljković, et al., "Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases", prezentirano na: 26th Congress of the European Hematology Association, Online, 09.06.2021.-17.06.2021. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:220:516465

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:220:516465
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases
AutorMateja Kolačević Zeljković
AutorNikola Bulj
AutorSandra Bašić-Kinda
AutorVibor Milunović
AutorDubravka Čaržavec
AutorOzren Jakšić
AutorMarijo Vodanović
AutorSlobodanka Ostojić-Kolonić
AutorPetar Gaćina
AutorD Dujmović
AutorIvan Željković
AutorVlatko Pejša
AutorIgor Aurer
Autorova ustanova(Klinički bolnički centar Sestre milosrdnice)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Prolonged treatment with ibrutinib had no significant impact on number of VPBs or SPBs. Our study suggests that ibrutinib does not significantly increase the propensity to develop dangerous cardiac arrhythmias in patients who do not have clinically important structural heart disease or arrhythmias prior to treatment start and stresses the importance of hypertension control in this group of patients.
Jezikengleski
Vrsta recenzijeRecenziran - međunarodna recenzija
DOIhttps://doi.org/10.1097/HS9.0000000000000566
URN:NBNurn:nbn:hr:220:516465
Datum izlaganja2021-08-31
SkupNaziv: 26th Congress of the European Hematology Association
Kratica: EHA 2021
Lokacija: Online, Nizozemska
Organizator: European Hematology Association
Datum početka: 2021-06-09
Datum završetka: 2021-06-17
Vrsta izlaganja: Predavanje
URL dokumentahttps://journals.lww.com/hemasphere/Citation/2021/06002/EHA2021_Virtual_Congress_Abstract_Book.1.aspx
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno-Bez prerada 4.0 međunarodna (CC BY-NC-ND 4.0)
Datum i vrijeme pohrane2022-08-31 11:45:45